🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the service has taken down problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or injecting at home.

After minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Product Information and Costs

Within these groups, messages display black plastic packages with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to possibly significant medical dangers”.